Serial #97489701
DEAD

Serial Number

97489701

Owner

Genting TauRx Diagnostic Centre Sdn Bhd.

Attorney

Kim Cooper

Filing Date

Jul 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97489701 Trademark

Serial Number: 97489701

Serial #97489701 is a trademark filed by Genting TauRx Diagnostic Centre Sdn Bhd. on July 5, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

Genting TauRx Diagnostic Centre Sdn Bhd. (18 trademarks)

Wisma Genting, Jalan Sultan Ismail
Kuala Lumpur 50250 , MY

Entity Type: 99

Trademark Details

Filing Date

July 5, 2022

Registration Date

Not Registered

Published for Opposition

July 11, 2023

Goods & Services

Diagnostic kits comprising medical bioreagents for use in disease testing; medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations for medical use, namely, reagents for medical use; diagnostic tests for medical use, namely, medical diagnostic reagents; medical diagnostic assays for testing of body fluids; in vitro medical diagnostic tests, namely, medical diagnostic reagents; in vitro medical diagnostic assays for testing of body fluids; in vitro medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; in vitro medical diagnostic reagents; medical diagnostics tests, namely, medical diagnostic reagents for the detection, diagnosis and screening of neurological diseases and disorders, neurodegenerative diseases and disorders; medical diagnostics tests, namely, medical diagnostic reagents for the detection, diagnosis and screening of Alzheimer's disease and dementia

Paper; stationery; printed notepads; blank paper notebooks; folders being stationery; file folders; brochures, namely, printed brochures in the field of cognitive function and impairment; printed posters; writing implements, namely, writing instruments; pens; pencils; book markers; marker pens; document page markers; colored markers; highlighter pens; decals; stickers; transfers, namely, decals; printed calendars; printed diaries

Medical devices targeting the early detection, diagnosis, and monitoring of neurodegenerative disorders and cognitive impairment and monitoring the progression thereof; medical apparatus for the detection, diagnosis, and screening of Alzheimer's disease and dementia; in vitro medical diagnostic test kits comprised of medical diagnostic apparatus for the detection, diagnosis, and screening of Alzheimer's disease and dementia; medical diagnostic test kits comprised of medical diagnostic apparatus for the detection, diagnosis, and screening of Alzheimer's disease and dementia

Scientific and technological services and research and design relating thereto, namely, scientific research and development; industrial analysis and research services in the field of Alzheimer's disease and dementia; medical and scientific research; pharmaceutical research and development; research and development in the field of diagnostic preparations; research and development in the pathology of Alzheimer's disease and dementia; provision of laboratory testing and analysis services, namely, medical laboratory services; design and development of computer hardware and software; design and development of computer software for use with medical technology; design and development of medical technology; design and development of new technology for others; medical research; technological research in the field of medical instruments; scientific testing services, namely, scientific laboratory services; research, testing, development and industrial analysis services, all relating to the field of science, technology, diagnostics and the pathology of Alzheimer's disease and dementia; design and development of testing and analysis methods in the field of Alzheimer's disease and dementia; design and development of medical diagnostic kit; design and development of medical diagnostic apparatus; consultancy in the field of technological research; preparation of technological research reports, namely, engineering consultation; providing information, including online, about scientific and technological services and research and design relating thereto, namely, providing medical and scientific research information; technological consultancy, research, advisory and information services relating to the exploitation of technology, namely, technology consultation and research in the field of medical apparatus and instruments; preparation of technical reports, namely, engineering consultation; electronic storage of data; provision of information and data relating to medical and veterinary research and development, namely, medical and veterinary research consultation; design and development of systems for data input, output, processing, display and storage; provision of information, advisory and consultancy services in respect of all of the aforesaid services

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 9, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 9, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 10, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 10, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 10, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2024 EXRA
SOU EXTENSION 1 GRANTED
Feb 22, 2024 EX1G
SOU EXTENSION 1 FILED
Feb 22, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 22, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 5, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 11, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 21, 2023 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 8, 2023 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 4, 2023 GPRN
PRIORITY ACTION E-MAILED
May 4, 2023 GPRA
PRIORITY ACTION WRITTEN
May 4, 2023 CPRA
ASSIGNED TO EXAMINER
Apr 18, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 14, 2023 AMPX
ASSIGNED TO LIE
Feb 14, 2023 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 12, 2022 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 26, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2022 NWOS
NEW APPLICATION ENTERED
Jul 8, 2022 NWAP